Q1 2023 Inovio Pharmaceuticals Inc Earnings Call Transcript
Good day, and welcome to the Inovio First Quarter 2023 Financial Results Conference Call. (Operator Instructions)
I would now like to turn the conference over to Thomas Hong, Manager of Investor Relations. Please go ahead.
Good afternoon, and thank you for joining the Inovio 2023 first quarter conference call. Joining me on today's call are Dr. Jackie Shea, President and CEO; Dr. Michael Sumner, Chief Medical Officer; and Mr. Peter Kies, Chief Financial Officer. We also have other members of Inovio's leadership here with us today, who will be part of our Q&A session.
Today's call will review our corporate and financial information for the quarter and year ended March 31, 2023, as well as provide a development progress update for our DNA medicines platform. Following prepared remarks, we will conduct a question-and-answer segment.
During the call, we will be making forward-looking statements regarding future events and the future performance of the company. These events relate to our business plans to develop Inovio's DNA
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |